Skip to main content
Premium Trial:

Request an Annual Quote

Michael Young

Premium
Expressed RNAi-drug developer Nucleonics has appointed Michael Young as its chief medical officer.
 
Young joins Nucleonics from MDY-Associates, a strategic and technical consulting group where he served as president and managing consultant. Before this, he held a number of positions in the pharmaceutical industry including corporate director of worldwide regulatory and clinical development at Procter & Gamble. He holds a PhD in chemistry from the University of Wales and an MD from the Welsh School of Medicine.

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.